Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer

Abstract

It is widely accepted that disruption of the hedgehog-patched pathway is a key event in development of basal cell cancer. In addition to patched gene alterations, p53 gene mutations are also frequent in basal cell cancer. We determined loss of heterozygosity in the patched and p53 loci as well as sequencing the p53 gene in tumors both from sporadic and hereditary cases. A total of 70 microdissected samples from tumor and adjacent skin were subjected to PCR followed by fragment analysis and DNA sequencing. We found allelic loss in the patched locus in 6/8 sporadic basal cell cancer and 17/19 hereditary tumors. All sporadic and 7/20 hereditary tumors showed p53 gene mutations. Loss of heterozygosity in the p53 locus was rare in both groups. The p53 mutations detected in hereditary tumors included rare single nucleotide deletions and unusual double-base substitutions compared to the typical ultraviolet light induced missense mutations found in sporadic tumors. Careful microdissection of individual tumors revealed genetically linked subclones with different p53 and/or patched genotype providing an insight on time sequence of genetic events. The high frequency and co-existence of genetic alterations in the patched and p53 genes suggest that both these genes are important in the development of basal cell cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Aszterbaum M, Epstein J, Oro A, Douglas V, LeBoit PE, Scott MP, Epstein Jr EH . 1999 Nat. Med. 5: 1285–1291

  • Berg C, Hedrum A, Holmberg A, Pontén F, Uhlen M, Lundeberg J . 1995 Clin. Chem. 41: 1461–1466

  • Brash DE, Pontén J . 1998 Cancer Surv. 32: 69–113

  • Brash DE, Rudolph JA, Simon JA, Lin A, Mckenna GJ, Baden HP, Halperin AJ, Pontén J . 1991 Proc. Natl. Acad. Sci. USA 88: 10124–10128

  • D'Errico M, Calcagnile A, Canzona F, Didona B, Posteraro P, Cavalieri R, Corona R, Vorechovsky I, Nardo T, Stefanini M, Dogliotti E, Rebel H, Mosnier LO, Berg RJ, Westerman-de Vries A, van Steeg H, van Kranen HJ, de Gruijl FR . 2000 Oncogene 19: 463–467

  • Futreal PA, Barrett JC, Wiseman RW . 1991 Nucleic Acids Res. 19: 6977

  • Gailani MR, Bale AE . 1997 J. Natl. Cancer Inst. 89: 1103–1108

  • Gailani MR, Leffell DJ, Ziegler A, Gross EG, Brash DE, Bale AE . 1996 J. Natl. Cancer Inst. 88: 349–354

  • Gallagher RP, Hill GB, Bajdik CD, Fincham S, Coldman AJ, McLean DI, Threlfall WJ . 1995 Arch. Dermatol. 131: 157–163

  • Green A, Battistutta D, Hart V, Leslie D, Weedon D . 1996 Am. J. Epidemiol. 144: 1034–1040

  • Greenblatt MS, Bennett WP, Hollstein M, Harris CC . 1994 Cancer Res. 54: 4855–4878

  • Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J . 1994 Nat. Genet. 7: 246–339

  • Hahn H, Wiking C, Zaphiropoulos PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE . 1996 Cell 85: 841–851

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53

  • Holmberg E, Rozell BL, Toftgard R, Rebel H, Mosnier LO, Berg RJ, Westerman-de Vries A, van Steeg H, van Kranen HJ, de Gruijl FR . 1996 Br. J. Cancer 74: 246–250

  • Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein Jr EH, Scott MP . 1996 Science 272: 1668–1671

  • Jonason AS, Kunala S, Price GJ, Restifo RJ, Spinelli HM, Persing JA, Leffell DJ, Tarone RE, Brash DE . 1996 Proc. Natl. Acad. Sci. USA 93: 14025–14029

  • Jones MH, Nakamura Y . 1992 Genes Chrom. Cancer 5: 89–90

  • Kawanishi S, Hiraku Y, Oikawa S . 2001 Mutat. Res. 488: 65–76

  • Knudson AG, Hethcote HW, Brown BW, Levine AJ . 1975 Proc. Natl. Acad. Sci. USA 72: 5116–5120

  • Ling G, Persson Å, Berne B, Lundeberg J, Pontén F . 2001 Am. J. Pathol. 159: 1247–1253

  • Moles JP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C, Basset-Seguin N . 1993 Oncogene 8: 583–588

  • Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, Toftgard R . 2000 Proc. Natl. Acad. Sci. USA 97: 3438–3443

  • Pontén F, Berg C, Ahmadian A, Ren Z-P, Nistér M, Lundeberg J, Uhlén M, Pontén J . 1997 Oncogene 15: 1059–1067

  • Pontén F, Berne B, Ren Z, Nistér M, Pontén J . 1995 J. Invest. Dermatol. 105: 402–406

  • Ratner D, Peacocke M, Zhang H, Ping XL, Tsou HC . 2001 J. Am. Acad. Dermatol. 44: 293–297

  • Rebel H, Mosnier LO, Berg RJ, Westerman-de Vries A, van Steeg H, van Kranen HJ, de Gruijl FR . 2001 Cancer Res. 61: 977–983

  • Ren Z-P, Ahmadian A, Pontén F, Nistér M, Berg C, Lundeberg J, Uhlén M, Pontén J . 1997 Am. J. Pathol. 150: 1791–1803

  • Ren Z-P, Hedrum A, Pontén F, Nistér M, Ahmadian A, Lundeberg J, Uhlén M, Pontén J . 1996 Oncogene 12: 765–773

  • Sarasin A . 1999 Mutat. Res. 428: 5–10

  • Tabata H, Nagano T, Ray A, Flanagan N, Birch-MacHin M, Rees J . 1999 J. Invest. Dermatol. 113: 972–976

  • Taipale J, Beachy PA, Levine AJ . 2001 Nature 411: 349–354

  • Toftgard R . 2000 Cell. Mol. Life Sci. 57: 1720–1731

  • Undén AB, Zaphiropoulos PG, Bruce K, Toftgård R, Ståhle-Bäckdahl M . 1997 Cancer Res. 57: 2336–2340

  • Williams C, Pontén F, Ahmadian A, Ren ZP, Ling G, Rollman O, Ljung A, Jaspers NG, Uhlen M, Lundeberg J, Pontén J . 1998 Cancer Res. 58: 2449–2455

  • Zhang H, Ping XL, Lee PK, Wu XL, Yao YJ, Zhang MJ, Silvers DN, Ratner D, Malhotra R, Peacocke M, Tsou HC . 2001 Am. J. Pathol. 158: 381–385

  • Ziegler A-M, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, Brash DE . 1993 Proc. Natl. Acad. Sci. USA 90: 4216–4220

Download references

Acknowledgements

This study was supported by grants from The Swedish Cancer Foundation and The Foundation for Strategic Research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fredrik Pontén.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ling, G., Ahmadian, A., Persson, Å. et al. PATCHED and p53 gene alterations in sporadic and hereditary basal cell cancer. Oncogene 20, 7770–7778 (2001). https://doi.org/10.1038/sj.onc.1204946

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1204946

Keywords

This article is cited by

Search

Quick links